Home / Industries / Pharmaceuticals

Reports

The Global Pemphigus Vulgaris Market Size is estimated to reach USD 1119.42 million in 2034, growing at a CAGR of 8.2% during the forecast period (2026–2034).
The global biomarkers market size was valued at USD 101.38 billion in 2025 and is estimated to reach USD 301.64 billion by 2034, growing at a CAGR of 12.88% during the forecast period.
The global cancer immunotherapy drug discovery outsourcing market size is projected to grow from USD 1.98 billion in 2026 to USD 5.58 billion by 2034, registering a CAGR of 13.79% during the forecast period (2026–2034).
The global label-free detection market size is valued at USD 1.89 billion in 2025 and is estimated to reach USD 4.80 billion by 2034, growing at a CAGR of 10.93% during the forecast period.
The cyclosporine market size was valued at USD 2.11 billion in 2025 and is projected to reach USD 3.07 billion by 2034 at a CAGR of 4.28% from 2026 to 2034.
The angina pectoris drugs market size was valued at USD 12.15 billion in 2025 and is projected to reach USD 17.28 billion by 2034 at a CAGR of 4.01% from 2026 to 2034.
The rotavirus vaccines market size was valued at USD 5.58 billion in 2025 and is projected to reach USD 13.17 billion by 2034 at a CAGR of 12.02% from 2026 to 2034.
The global cerebral palsy treatment market size was valued at USD 3.58 billion in 2025 and is estimated to reach USD 4.74 billion by 2034, growing at a CAGR of 3.19% during the forecast period.
The pediatric vaccines market size was valued at USD 48.46 billion in 2025 and is projected to reach USD 69.67 billion by 2034 at a CAGR of 4.14% from 2026 to 2034.
The global animal vaccine market size was valued at USD 12 billion in 2025 and is estimated to reach USD 21 billion by 2034, growing at a CAGR of 6% during the forecast period.
The complementary and alternative medicine market size was valued at USD 275.52 billion in 2025 and is projected to grow from USD 347.43 billion in 2026 to USD 2272.19 billion by 2034 at a CAGR of 26.46% during the forecast period (2026-2034), as per Straits Research Analysis.
The hydroxychloroquine market size was valued at USD 1.16 billion in 2025 and is projected to reach USD 1.80 billion by 2034 at a CAGR of 5.03% from 2026 to 2034.
The regenerative medicine market size was valued at USD 41.32 billion in 2025 and is projected to reach USD 168.31 billion by 2034 at a CAGR of 16.93% from 2026 to 2034.
The global prebiotics market size was valued at USD 10.05 billion in 2025 and is projected to reach USD 34.00 billion by 2034, growing at a CAGR of 14.54% from 2026 to 2034.
The global astaxanthin market size was valued at USD 1.93 billion in 2025 and is estimated to reach USD 9.52 billion by 2034, growing at a CAGR of 9.52% during the forecast period.
The pharmaceutical manufacturing market size was valued at USD 636.80 billion in 2025 and is projected to reach USD 1221.73 billion by 2034 at a CAGR of 7.55% from 2026 to 2034.
The ambulatory surgery center (ASC) market size was valued at USD 151.96 billion in 2025 and is projected to grow from USD 161.29 billion in 2026 to USD 263.26 billion by 2034 at a CAGR of 6.32% during the forecast period (2026-2034), as per Straits Research Analysis.
The global anesthesia drugs market size was valued at USD 5.47 billion in 2025 and is estimated to reach USD 7.63 billion by 2034, growing at a CAGR of 3.78% during the forecast period.
The global alopecia market size is valued at USD 9.37 billion in 2025 and is estimated to reach USD 49.30 billion by 2034, growing at a CAGR of 7.75% during the forecast period.
The global aesthetic medicine market size is valued at USD 99.77 billion in 2025 and is estimated to reach USD 111.13 billion by 2034, growing at a CAGR of 11.74% during the forecast period.
WhatsApp
Chat with us on WhatsApp